Dapagliflozin prevents ejection fraction and fractional shortening reduction, reduces myocardial NF-KB expression and systemic pro-inflammatory biomarkers in models of doxorubicin cardiotoxicity
11 December 2024 (09:30 - 17:45)
Organised by: 
Abstract
Slides
About the speaker
National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)
83 More presentations in this session
Miss L. Al Saikhan (Dammam, SA)
Doctor S. Saraiya (Vadodara, IN)
Doctor M. Pandrc (Belgrade, RS)
Access the full session
The Event
EuroEcho-Imaging 2024
11 December 2024
09:30 CET
You may be interested in
Congress Session
Congress Session
